Lv2
110 积分 2025-11-09 加入
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
4天前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
4天前
已完结
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
3个月前
已关闭
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
3个月前
已完结
Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK/T-cell lymphoma
4个月前
已完结
皖公网安备34019202002308
